An observational study in Acquired Immunodeficiency Syndrome, sponsored by National Center for AIDS/STD Control and Prevention, China CDC. Completed at 1 site in China. Open to participants aged Up to 15 Years. Per ClinicalTrials.gov, last updated 2018-03-30.
Sponsored by National Center for AIDS/STD Control and Prevention, China CDC · Observational
This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.
2,040 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 272 are open to participants now.
This study's enrollment of 400 is above the median of 236 across 355 observational studies indexed under Acquired Immunodeficiency Syndrome.
Browse Acquired Immunodeficiency Syndrome studies →National Center for AIDS/STD Control and Prevention, China CDC is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Pediatric HIV-infected patients receiving triple antiretroviral drugs
Exclusion Criteria:
The immunology and virologic outcomes
Time frame: 2016
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Acquired Immunodeficiency Syndrome→
National Center for AIDS/STD Control and Prevention, China CDC